Sunday, July 22, 2018
 
 
Company News: Page (1) of 1 - 07/10/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
ProAssurance Corporation Announces Dates for Second Quarter 2018 Earnings Release and Conference Call
 
(July 10, 2018)

BIRMINGHAM, Ala., July 10, 2018 /PRNewswire/ -- ProAssurance Corporation (NYSE: PRA) will report results for the second quarter of 2018 after the close of normal New York Stock Exchange trading on Tuesday, August 7, 2018.

Corporate Logo. (PRNewsFoto/ProAssurance) (PRNewsFoto/)

ProAssurance will conduct a conference call at 10:00 am et on Wednesday, August 8, 2018 to discuss the results, and other items of interest to investors participating in the call. US-based investors are invited to participate by phone by dialing (888) 349-0134 (toll free), Canadian investors may dial (855) 669-9657 (toll free), and international investors may dial (412) 317-5145. The conference call will also be webcast through the Investor Relations section of ProAssurance.com.



A telephone replay of the call will be available through at least October 31, 2018 at (877) 344-7529 (toll free), Canadian investors may dial (855) 669-9658 (toll free), and international investors may dial (412) 317-0088; all using access code 10122248. A replay will be available on the internet through June 30, 2019 at ProAssurance.com. ProAssurance will make a podcast of the call available on its website and on iTunes.

About ProAssurance
ProAssurance Corporation is an industry-leading specialty insurer with extensive expertise in healthcare professional liability, products liability for medical technology and life sciences, legal professional liability, and workers' compensation insurance. The company is recognized as one of the top performing insurance companies in America by virtue of our inclusion in the Ward's 50 for the past eleven years. ProAssurance Group is rated "A+" (Superior) by A.M. Best; ProAssurance and its operating subsidiaries are rated "A" (Strong) by Fitch Ratings.

For the latest on ProAssurance and its industry leading suite of products and services, cutting edge risk management and practice enhancement programs follow @ProAssurance on Twitter or LinkedIn. ProAssurance's YouTube channel regularly presents thought provoking, insightful videos that communicate effective practice management, patient safety and risk management strategies.

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/proassurance-corporation-announces-dates-for-second-quarter-2018-earnings-release-and-conference-call-300678819.html

SOURCE ProAssurance Corporation

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:healthcare,Technology,Surgery,Science,Medical Technology,Internet Technology,Medical,Internet,Other,
Related Sites: Digital Producer ,   Corporate Media News ,   Digital Post Production ,   DVD Creation ,   DMN Newswire ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Timeline Newsletter ,   DVD Viewpoint ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

    Cancer
  • CStone Pharmaceuticals Appoints Former Goldman Sachs Executive Richard Yeh as CFO
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines